Thyssenkrupp AG O.N. (0O1C)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 13.93 |
|---|---|
| 52-week range | 7.12 – 15.87 |
| Return, 1 month / 3 months | −8.4% / +14.4% |
| Return, 1 year / 3 years | +46.8% / +204.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 55.6% |
| Worst drawdown (1 year) | -41.9% |
| Average daily value traded | 13.11M EUR |
| Dividend yield | 22.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Thyssenkrupp is a German industrial group based in Essen that makes steel and provides engineering and component products for industry. Its operations span steel production, automotive parts, plant engineering and materials trading, serving manufacturers, construction firms and industrial customers around the world. The company also supplies elevators and related services through its elevator business, which has been a major part of the group.
On this site Thyssenkrupp AG O.N. appears as a stock on the London Exchange (UK), code 0O1C, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Thyssenkrupp AG O.N. (0O1C) trades on the London Exchange in UK. It last closed at EUR 13.93 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 811 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 46.8% and over the last three months it rose 14.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.5% | ||
| From 52-week high | -11.1% | ||
| Momentum | 90 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 14.4% | ||
| 6-month return | 56.0% | ||
| 12-month return, skipping the last month | 60.3% | ||
| Stability (higher is calmer) | 26 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.9% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 13.11M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 22.6% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | −8.4% |
| 3 months | +14.4% |
| 6 months | +56.0% |
| 1 year | +46.8% |
| 3 years | +204.1% |
| 5 years | +130.0% |
Signals
| 50-day / 200-day average | 14.22 / 11.37 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Feb 2026 | EUR 0.1500 |
| 20 Oct 2025 | EUR 3.0000 |
| 3 Feb 2025 | EUR 0.1125 |
| 5 Feb 2024 | EUR 0.1125 |
| 6 Feb 2023 | EUR 0.1125 |
| 4 Feb 2019 | EUR 0.0015 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.